Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

SLV-154 Treatment of Advanced Cancers

for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: Solve Therapeutics

Sex: All

Age: 12+

Code: NCT06771219

Phase 1, Recruiting

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Dallas TX, Denver CO, San Diego CA
Sponsor: Acepodia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06415487

Phase 1, Recruiting

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

for
Head and Neck Cancers- Squamous Cell, Head and Neck Cancer,
Location: Stanford CA
Sponsor: VLP Therapeutics

Sex: All

Age: 18+

Code: NCT06736379

Phase 1, Recruiting

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

for
Relapsed or Refractory Lymphomas, Advanced Solid Tumor
Location: West Valley City UT
Sponsor: Lantern Pharma Inc.

Sex: All

Age: 18+

Code: NCT06132503

Phase 1, Recruiting

Leading Healthy Eating and Activity Promotion Program

for
Cancer Survivor, Cancer, Oncology
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT06868524

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients

for
Malnutitrion, Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT07776704

Recruiting

Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06949943

Recruiting

BRIDGE-SIC Efficacy Trial

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07735442

Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Lake Success NY, Grand Rapids MI, Houston TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06242470

Phase 1, Recruiting

Unified Network for Integrated Fluid Collection at Yale

for
Molecular Residual Disease, Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07689864

Recruiting

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

for
Multiple Endocrine Neoplasia, Pancreatic Neuroendocrine Tumors,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03053999

Recruiting

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

for
Neoplasms
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04449549

Phase 2, Recruiting

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: Boston MA, Fairfax VA, Lake Mary FL, Denver CO,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06907043

Phase 1, Phase 2, Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)

for
Pancreatic Adenocarcinoma, Weight Loss
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT06988150

Recruiting

Pan Tumor Rollover Study

for
Cancer
Location: Boston MA, Mineola NY, Lancaster PA, Toronto,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT03899155

Phase 2, Recruiting

First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, San Antonio TX, Duarte CA
Sponsor: VelaVigo Bio Inc

Sex: All

Age: 18+

Code: NCT07700160

Phase 1, Phase 2, Recruiting

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

for
Cancer, Medication Adherence
Location: Cincinnati OH, Seattle WA
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 15 - 24

Code: NCT07223463

Recruiting

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

for
Tumor, Liver
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07444645

Recruiting

B7-H3.CD28Z.CART in Solid Tumors

for
Pediatric Solid Tumor, Neuroblastoma
Location: Boston MA
Sponsor: Robbie Majzner

Sex: All

Age: 0 - 30

Code: NCT07358260

Phase 1, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial